BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2197239)

  • 41. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
    Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
    Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.
    Gitsch G; Kohlberger P; Hanzal E; Kölbl H; Breitenecker G
    Arch Gynecol Obstet; 1991; 249(4):173-7. PubMed ID: 1665684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histogenesis of Brenner tumors, II: histochemistry and CEA.
    Shevchuk MM; Fenoglio CM; Richart RM
    Cancer; 1980 Dec; 46(12):2617-22. PubMed ID: 7004621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histochemical study of mucinous ovarian cystomas of intestinal and mixed types: O-acetylated sialomucin content in relation to biologic behavior.
    Fulcheri E; Baracchini P; Foglia G; Lapertosa G; Siciliano B; Ragni N
    Tumori; 1990 Feb; 76(1):73-6. PubMed ID: 2321278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
    Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
    Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mucosubstances in classification of serous and mucinous ovarian tumors: a morphometrical study.
    Aalto ML
    Eur J Obstet Gynecol Reprod Biol; 1986 Jul; 22(3):139-44. PubMed ID: 3732584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathology of mucinous ovarian cystadenomas. I. Argyrophil and argentaffin cells and epithelial mucosubstances.
    Klemi PJ
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):465-70. PubMed ID: 716907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S; Aoki D; Yajima M; Tsukazaki K; Kobayashi T; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
    Cancer Res; 1992 Mar; 52(5):1205-9. PubMed ID: 1737381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
    Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
    Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intestine-associated antigens in ovarian tumours: an immunohistological study.
    De Boer WG; Ma J; Nayman J
    Pathology; 1981 Jul; 13(3):547-55. PubMed ID: 7029434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein.
    Konishi I; Fujii S; Kataoka N; Noda Y; Okamura H; Yamabe H; Mori T
    Int J Gynecol Pathol; 1988; 7(2):182-9. PubMed ID: 2456275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors.
    Yamada K; Ohkawa K; Joh K
    Am J Clin Pathol; 1995 Mar; 103(3):288-94. PubMed ID: 7872250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
    Devaney K; Goodman ZD; Ishak KG
    Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Common epithelial tumors of borderline malignancy (carcinomas of low malignant potential).
    Scully RE
    Bull Cancer; 1982; 69(3):228-38. PubMed ID: 6289947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneous distribution of K-ras-mutated epithelia in mucinous ovarian tumors with special reference to histopathology.
    Mandai M; Konishi I; Kuroda H; Komatsu T; Yamamoto S; Nanbu K; Matsushita K; Fukumoto M; Yamabe H; Mori T
    Hum Pathol; 1998 Jan; 29(1):34-40. PubMed ID: 9445131
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of Vicia graminea lectin- and Vicia unijuga lectin-binding glycoproteins as novel oncofetal antigens in cyst and ascitic fluids of human ovarian tumors in benign, dysplastic, and malignant stages.
    Ohyama K; Yanagi K; Hayashi S; Matsuda T; Suzuki R; Ohkuma S; Watanabe H; Hirakawa S; Yamakawa T
    Cancer Detect Prev; 1997; 21(4):304-11. PubMed ID: 9232320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.